The quest for a headache pattern in giant cell arteritis: A cohort study

Autor: Sanne CC Vincenten, Wim M Mulleners

Publikováno v: Cephalalgia Reports, Vol 4 (2021)

Aim: To help clinicians in the diagnostic approach of giant cell arteritis (GCA) by providing a better knowledge on headache patterns in GCA. Methods: Cross-sectional data of a cohort of 30 known GCA patients regarding symptoms, clinical signs, labor

Externí odkaz: https://doaj.org/article/3e6dfd4973e848f9a4d09eed4d1f1983

Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON)

Autor: Joost Haan, P.G.G. Doesborg, Wim M Mulleners, Patty G.G. Doesborg, Onno P.M. Teernstra, Volker M. Tronnier, I.F. de Coo, Dirk Rasche, Katja Bürger, L.G. Eross, K. Burger, G.H. Spincemaille, Frank J P M Huygen, Wim M. Mulleners, Michel D. Ferrari, Erik W. van Zwet, E.W. van Zwet, Ilse F. de Coo, E.G.M. Couturier, Hartmut Göbel, F. Wille, F.J.P.M. Huygen, Frank Wille, E.C. Bartels, Geert H. Spincemaille, O.P.M. Teernstra, Delphine Magis, R.T.M. van Dongen, Jan Willem Kallewaard, Robert van Dongen, Eveline C Bartels, J. Afra, Jean Schoenen, M. D. Ferrari, Petrus H. Veltink, L.A. Wilbrink, Leopoldine A Wilbrink, E. Kurt, J. Haan, Axel Heinze, Erkan Kurt, Peter J. Koehler

Publikováno v: Lancet Neurology, 20(7), 515-525. Elsevier Science
The Lancet Neurology, 20(7), 515-525. Lancet Publishing Group
Lancet Neurology, 20, 515-525
The Lancet Neurology, 20(7), 515-525. ELSEVIER SCIENCE INC
Lancet neurology, 20(7), 515-525. Lancet Publishing Group
Lancet Neurology, 20, 7, pp. 515-525

Contains fulltext : 234463.pdf (Publisher’s version ) (Closed access) BACKGROUND: Occipital nerve stimulation (ONS) has shown promising results in small uncontrolled trials in patients with medically intractable chronic cluster headache (MICCH). We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a1845d2e4c5403f274a7babc0b530a
https://pure.eur.nl/en/publications/05ced605-a2f1-474d-8751-fb3c297c7200

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Autor: Miguel J. A. Láinez, Laura Yunes-Medina, Antje Tockhorn-Heidenreich, Holland C. Detke, Wim M Mulleners, Russell M Nichols, Byung-Kun Kim, Michel Lanteri-Minet, Sheena K. Aurora, Patricia Pozo-Rosich, Shufang Wang

Publikováno v: The Lancet Neurology. 19:814-825

Many patients who require migraine preventive treatment have not been able to tolerate or have not responded to multiple previous preventive medications. We aimed to assess the safety and efficacy of galcanezumab, an antibody to calcitonin gene-relat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f524ae3dcc5cf053f7d9f282f26a822
https://doi.org/10.1016/s1474-4422(20)30279-9

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke : A multicentre, double-blind, randomised, placebo-controlled trial

Autor: Peter D. Schellinger, Agnes Koves, Usman A. Khan, Didier Smadja, Gabriel Rodriguez Freitas, Ralf Lindert, Bill O'brien, Jaime Masjuan Vallejo, Aida Lago Martin, Cesar Minelli, Hassan Hosseini, Marine Wattez, Martin Grond, Claudio L. Bassetti, Konrad Rejdak, Marie-Laure Audoli-Inthavong, Luisa Rover, Pere Cardona, Kenneth Butcher, Gabriel R. de Freitas, Gyula Panczel, Tomas Segura Martin, Marianna Gottschal, Maurício André Gheller Friedrich, Hugues Chabriat, Alvaro Ximenez Carrillo, Laura Dorado, Jean-Philippe Neau, Joerg Berrouschot, D. G. Nabavi, Carla H.C. Moro, Nina De Klippel, Norbert Szegedi, Tomasz Berkowicz, Jesse Dawson, Andras Folyovich, Christian Denier, Jean-Louis Mas, Klaus Gröschel, Amit K Mistri, Thanh G. Phan, Timothy Kleinig, Aurore Sors, Dirk M. Hermann, Louise Shaw, Christine Roffe, Nikola Sprigg, Man Seok Park, Hans-Christoph Diener, Hassan Soda, Maite Martinez Zabaleta, Pietro Bassi, Luiz Carlos Porcello Marrone, Dylan Blacquiere, László Vécsei, Stephen N. Davis, Giuseppe Lembo, Rohan Grimley, Charlotte Cordonnier, Geert Vanhooren, Bernd Kallmuenzer, Peter Dioszeghy, Mikael Mazighi, Waldemar Brola, Francisco Moniche Alvarez, Yangha Hwang, Attila Valikovics, Waldemar Fryze, Philippe Desfontaines, Jaume Roquer Gonzalez, David Cohen, Zbigniew Bak, Csaba Ovary, Jae-Kwan Cha, Gisele Sampaio Silva, Carlos A. Molina, Rodrigo Bazan, Hee-Joon Bae, Rubens José Gagliardi, Geoffrey Cloud, Anna Członkowska, Attila Csanyi, Leonardo Barbarini, Sergi Amaro, Jong Sung Kim, Daniel Bereczki, Katharina Althaus, Robin Lemmens, Anetta Lasek-Bal, Theodore Wein, Piotr Sobolewski, Diederik Willem Dippel, Danilo Toni, Laszlo Szapary, Suzanne Ragab, Andrew Wong, Ute Marx, Estelle Lambert, Igor Sibon, Wim M. Mulleners, Ondrej Skoda, Maciej Swiat

Summary Background S44819, a selective GABAA α5 receptor antagonist, reduces tonic post-ischaemic inhibition of the peri-infarct cortex. S44819 improved stroke recovery in rodents and increased cortical excitability in a transcranial magnetic stimul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b691f063532bca5bfdd45c9b4f2ad883
https://iris.uniroma1.it/handle/11573/1474965

Étude de phase III, contrôlée, randomisée, de supériorité de galcanézumab versus placebo, chez les patients atteints de migraine difficile à traiter : résultats de l’étude CONQUER

Autor: Shufang Wang, Miguel J. A. Láinez, Wim M Mulleners, Antje Tockhorn-Heidenreich, Russell M Nichols, Michel Lanteri-Minet, Sheena K. Aurora, Holland C. Detke, Byung-Kun Kim

Publikováno v: Revue Neurologique. 176:S100

Introduction CONQUER est une etude controlee de phase III ayant concerne la prophylaxie des patients migraineux difficiles a traiter. Objectifs Evaluer l’efficacite et la securite d’emploi de galcanezumab chez des patients atteints de migraine ep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a985f7d0dc8fa7ba4a1bd6450a490925
https://doi.org/10.1016/j.neurol.2020.01.286